Efficacy of isatuximab/pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA-MM high-risk cytogenetics subgroup analysis.
Saved in:
| Title: | Efficacy of isatuximab/pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA-MM high-risk cytogenetics subgroup analysis. |
|---|---|
| Authors: | Harrison, Simon J., Richardson, Paul G., Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sossana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong, Kwee, Campana, Frank, Inchauspé, Marlène, Macé, Sandrine, Risse, Marie-Laure, van de Velde, Helgi, Attal, Michel |
| Source: | Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19. |
| Journal Info: | Publisher: Elsevier B.V. ISSN: 2152-2650 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2019.09.049 |
